G1 Therapeutics to Present at Cowen and Company 39th Annual Healthcare Conference

NEXT STORY
Translate Bio to Present at the 39th Annual Cowen and Company Healthcare Conference
PREV STORY
Ascendis Pharma Announces Once-weekly TransCon™ Growth Hormone Demonstrated Superiority on Primary Endpoint Compared to a Daily Growth Hormone in Phase 3 heiGHt Trial for Pediatric Growth Hormone Deficiency
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Takeda’s Area Offices in Dubai, United Arab Emirates Certified Sustainable and Inaugurated

author_avatar
NASDAQ Market News

Vincerx Pharma Announces Formation of Scientific Advisory Board to Advance its Clinical Pipeline

author_avatar
NASDAQ Market News

Hospital Architecture Market to Exhibit Promising CAGR Driven By Rising Demand Witnessed Worldwide, says Fortune Business Insights

author_avatar
NASDAQ Market News